News | April 20, 2015

Susan G. Komen Advocates Petition Congress on Breast Cancer Screening Access

Joan Lunden among advocates calling for increased screening access, parity of insurance coverage for treatment options

Komen, advocates, breast cancer, Congress, Joan Lunden, Brinker, Salerno

Nancy G. Brinker (left), founder and chair of global strategy for Susan G. Komen breast cancer survivor and former \"Good Morning America\" host Joan Lunden (center) and Komen President and CEO Judy Salerno, M.D., (right) at the Komen Advocacy Summit. Photo courtesy of Business Wire.

April 20, 2015 — Members of the Susan G. Komen Foundation took to the nation’s capitol April 16 to advocate for the importance of access to cancer screening programs. The group also called on policy makers to ensure parity of insurance coverage between oral chemotherapy and traditional IV treatments.   

Among the group was breast cancer survivor and former “Good Morning America” host Joan Lunden. Lunden, who was diagnosed with triple negative breast cancer last summer, met with members of her home state of Connecticut — including U.S. Sen. Chris Murphy and Rep. Rosa DeLauro — to talk about her experience with breast cancer. She stressed the importance of women knowing about breast density, and pushing to have a secondary screening if they have dense breast tissue, an action that found her breast cancer after receiving a clean mammogram.

Komen advocates from its community Affiliate Network visited 360 offices in both the House and Senate to push for maintaining the government’s commitment to vital safety net programs, such as the National Breast and Cervical Cancer Early Detection Program. They also discussed the importance of ensuring parity between the way insurance covers oral chemotherapy, which often is governed by prescription drug benefit rules, and traditional IV treatments, which often have lower co-pays.

“Everything we do is aimed at ending this disease, and helping the millions of people who need us, every single day,” said Judith A. Salerno, M.D., M.S., Komen’s president and CEO, noting that Komen is also encouraging increases for biomedical research funding. “The fact is that biomedical research funding has dropped by 25 percent in real dollar terms over the past 10 years and we run the risk that medical research will stall. We urge the federal government to increase this important funding.”

The Summit kicked off with a dinner that featured remarks from Lunden, who discussed how her diagnosis has inspired her to educate other women. She was joined by Salerno and Nancy Brinker, Susan G. Komen founder and chair of global strategy. The week ended with a lunch featuring a talk from singer and songwriter Nikia Hammonds-Blakely, a breast cancer survivor who was diagnosed with the disease when she was 16 years old.

For more information:

Related Content

Breast Cancer Places Greater Financial Burden on Black Women
News | Women's Health | May 16, 2018
Having breast cancer placed a significantly greater financial strain on black women than white women, according to a...
FDA's MQSA Accreditation Bodies Approved for Tomosynthesis Accreditation

Image courtesy of Fujifilm.

Feature | Mammography | May 14, 2018
On April 9, 2018, the U.S. Food and Drug Administration (FDA) announced that all four of its Mammography Quality...
Videos | Breast Imaging | May 08, 2018
ITN Associate Editor Jeff Zagoudis speaks with Karen Hou, M.D., breast radiologist at Northwestern Medicine Central D
3D-4D ultrasound of a fetus imaged with a GE Volusion E10 system. It shows the yoke sac. This is a baby ultrasound, also referred to as fetal ultrasound or prenatal ultrasound.

3D-4D ultrasound of a fetus imaged with a GE Volusion E10 system. It shows the yoke sac.

Feature | Ultrasound Women's Health | May 07, 2018
Below is a collection of prenatal ultrasound images from the ITN archive.
Hologic Clarity

Photo courtesy of Hologic.

Feature | Breast Imaging | May 03, 2018 | By Melinda Taschetta-Millane
The global breast imaging market is expected to reach $7.3 billion by 2024, according to a new report by Grand View R
Guideline updates and clinical research highlight the need for improved understanding of gender differences by clinicians and patients
Feature | Women's Health | May 03, 2018 | By Jeff Zagoudis
Clinical research has revealed men and women often have different presentations for cardiovascular disease (CVD).
Computer Error Leads to 450,000 Missed U.K. Breast Screening Invites
News | Mammography | May 02, 2018
Since 2009, approximately 450,000 women around age 70 in the United Kingdom did not receive final breast screening...
Overlay Init